Japan · Delayed Price · Currency is JPY Soiken Holdings Company Description
Soiken Holdings Inc. engages in the development of biomarkers in Japan.
It is involved in the development and sale of cosmetics and dietary supplements comprising imidapeptides; licensing and development of biomarker technology; provision of marketing research and post-marketing surveys for dietary supplements; and research, development, and sale of functional materials, such as lactoferrin, as well as pharmaceutical products from ascochlorin derivatives.
The company also provides clinical evaluation tests for foodstuffs using biomarker technology; support for pharmaceutical clinical research and epidemiology studies; and services to health insurance societies, including contracted health guidance, specific health checkup promotion services for the dependents of insured, and service to prevent diabetes.
Soiken Holdings Inc. was incorporated in 1994 and is headquartered in Toyonaka, Japan.
| Country | Japan |
| Founded | 1994 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 81 |
| CEO | Kentaro Ishigami |
Contact Details
Address: Senri Life Science Center Toyonaka, Osaka 560-0082 Japan | |
| Phone | 81 6 6871 8888 |
| Website | soiken.com |
Stock Details
| Ticker Symbol | 2385 |
| Exchange | Tokyo Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | July - June |
| Reporting Currency | JPY |
| ISIN Number | JP3431850001 |
| SIC Code | 2844 |
Key Executives
| Name | Position |
|---|---|
| Kentaro Ishigami | Chief Executive Officer |